Pacira News

This is selected news for Pacira, which is filed under Sectors / Healthtech. There are 2.3K news items for this page. Pacira is occasionally combined with Dave Stack, Frontier Capital and Stephens Investment Management in news items. A press release filter page is also available for Pacira.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
12/3/2022 Pacira BioSciences, Inc. (NASDAQ:PCRX) Stock Holdings Lifted by Rhumbline Advisers - Watch List News
Rhumbline Advisers raised its stake in Pacira BioSciences, Inc. ( NASDAQ:PCRX ‚Ai Get Rating ) by 7.4% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 125,635 shares of the company's stock after buying an additional 8,623 shares during the ...
watchlistnews.com
12/3/2022 Pacira BioSciences, Inc. (NASDAQ:PCRX) Stock Holdings Lifted by Rhumbline Advisers
Rhumbline Advisers raised its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX ‚Ai Get Rating) by 7.4% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 125,635 shares of the company's stock after buying an additional 8,623 shares during the ...
defenseworld.net
11/30/2022 Renaissance Technologies LLC Buys 104,500 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) - Mayfield Recorder
Renaissance Technologies LLC increased its holdings in Pacira BioSciences, Inc. ( NASDAQ:PCRX ‚Ai Get Rating ) by 5.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,965,497 shares of the company's stock after purchasing an additional 104,500 ...
Mayfield Recorder
11/29/2022 9,724 Shares in Pacira BioSciences, Inc. (NASDAQ:PCRX) Purchased by Virginia Wealth Management Group Inc. - The Cerbat Gem
Virginia Wealth Management Group Inc. acquired a new position in shares of Pacira BioSciences, Inc. ( NASDAQ:PCRX ‚Ai Get Rating ) in the second quarter, Holdings Channel.com reports. The institutional investor acquired 9,724 shares of the company's stock, valued at approximately $567,000. Several other large investors have also recently modified ...
thecerbatgem.com
11/29/2022 9,724 Shares in Pacira BioSciences, Inc. (NASDAQ:PCRX) Bought by Virginia Wealth Management Group Inc. - Financial News Live
Virginia Wealth Management Group Inc. purchased a new stake in Pacira BioSciences, Inc. (NASDAQ:PCRX ‚Ai Get Rating) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 9,724 shares of the company's stock, valued at approximately $567,000 ...
finnewslive.com
11/27/2022 Pacira BioSciences, Inc. (NASDAQ:PCRX) Position Boosted by Mutual of America Capital Management LLC
Mutual of America Capital Management LLC lifted its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX ‚Ai Get Rating) by 18.9% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 7,631 shares of the company's stock after purchasing an ...
defenseworld.net
11/27/2022 Mutual of America Capital Management LLC Acquires 1,212 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)
Mutual of America Capital Management LLC boosted its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX ‚Ai Get Rating) by 18.9% in the second quarter, Holdings Channel reports. The firm owned 7,631 shares of the company's stock after purchasing an additional 1,212 shares during the quarter. Mutual of America Capital ...
etfdailynews.com
11/25/2022 Public Sector Pension Investment Board Purchases 971 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)
Public Sector Pension Investment Board raised its position in Pacira BioSciences, Inc. (NASDAQ:PCRX ‚Ai Get Rating) by 1.2% in the 2nd quarter, Holdings Channel reports. The firm owned 84,111 shares of the company's stock after buying an additional 971 shares during the quarter. Public Sector Pension Investment Board ...
baseballnewssource.com
11/25/2022 Pacira BioSciences, Inc. (NASDAQ:PCRX) Stake Increased by Axxcess Wealth Management LLC
Axxcess Wealth Management LLC boosted its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX ‚Ai Get Rating) by 23.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,895 shares of the company's stock ...
American Banking News
11/25/2022 Public Sector Pension Investment Board Has $4.90 Million Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Ticker Report
Public Sector Pension Investment Board lifted its position in shares of Pacira BioSciences, Inc. ( NASDAQ:PCRX ‚Ai Get Rating ) by 1.2% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 84,111 shares of the company's stock after purchasing an additional ...
Ticker Report
11/24/2022 Polaris Capital Management LLC Boosts Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Stock Observer
Polaris Capital Management LLC boosted its stake in shares of Pacira BioSciences, Inc. ( NASDAQ:PCRX ‚Ai Get Rating ) by 38.4% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 11,900 shares of the company's stock after acquiring an additional 3,300 shares ...
thestockobserver.com
11/22/2022 Clearbridge Investments LLC Buys 447 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)
Clearbridge Investments LLC increased its stake in shares of Pacira BioSciences, Inc. ( NASDAQ:PCRX ‚Ai Get Rating ) by 0.0% during the 2nd quarter, Holdings Channel.com reports. The fund owned 1,126,100 shares of the company's stock after purchasing an additional 447 shares during the quarter. Clearbridge Investments LLC's holdings ...
American Banking News
11/21/2022 Envestnet Asset Management Inc. Sells 992 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)
Envestnet Asset Management Inc. trimmed its position in Pacira BioSciences, Inc. (NASDAQ:PCRX ‚Ai Get Rating) by 3.7% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,922 shares of the company's stock after selling 992 shares ...
defenseworld.net
11/19/2022 Shell Asset Management Co. Has $250,000 Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)
Shell Asset Management Co. lifted its position in Pacira BioSciences, Inc. ( NASDAQ:PCRX ‚Ai Get Rating ) by 30.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,296 shares of the company's stock after buying an ...
etfdailynews.com
11/19/2022 Martingale Asset Management L P Increases Stock Position in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Ticker Report
Martingale Asset Management L P boosted its stake in Pacira BioSciences, Inc. ( NASDAQ:PCRX ‚Ai Get Rating ) by 1.0% during the 2nd quarter, HoldingsChannel reports. The fund owned 29,712 shares of the company's stock after buying an additional 291 shares during the period. Martingale Asset Management L P's ...
Ticker Report
11/18/2022 Maryland Capital Management Grows Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Transcript Daily
Maryland Capital Management raised its position in Pacira BioSciences, Inc. ( NASDAQ:PCRX ‚Ai Get Rating ) by 29.8% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,829 shares of the company's stock after purchasing ...
transcriptdaily.com
11/18/2022 Maryland Capital Management Grows Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Stock Observer
Maryland Capital Management increased its position in shares of Pacira BioSciences, Inc. ( NASDAQ:PCRX ‚Ai Get Rating ) by 29.8% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 5,829 shares of the company's stock after purchasing an additional 1,339 shares during the period. Maryland Capital Management's holdings in ...
thestockobserver.com
11/18/2022 State Board of Administration of Florida Retirement System Has $900,000 Stake in Pacira BioSciences, Inc. (NASDAQ:PCRX)
State Board of Administration of Florida Retirement System trimmed its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX ‚Ai Get Rating) by 11.5% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,442 shares of the company's stock ...
etfdailynews.com
11/18/2022 Pacira BioSciences (NASDAQ:PCRX) Reaches New 52-Week Low at $46.90
Pacira BioSciences, Inc. ( NASDAQ:PCRX ‚Ai Get Rating ) shares reached a new 52-week low on Wednesday . The company traded as low as $46.90 and last traded at $47.21, with a volume of 13051 shares. The stock had previously closed at $50.00. Analyst Upgrades and Downgrades A number of equities ...
zolmax.com
11/18/2022 Pacira BioSciences (NASDAQ:PCRX) Hits New 12-Month Low at $46.90
Shares of Pacira BioSciences, Inc. ( NASDAQ:PCRX ‚Ai Get Rating ) reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $46.90 and last traded at $47.21, with a volume of 13051 shares. The stock had previously closed at $50.00. Analyst Upgrades and ...
baseballnewssource.com
11/18/2022 Pacira BioSciences, Inc. (NASDAQ:PCRX) Given Average Rating of “Moderate Buy” by Brokerages
Pacira BioSciences, Inc. (NASDAQ:PCRX ‚Ai Get Rating) has earned a consensus rating of ‚AuModerate Buy‚Au from the eleven research firms that are presently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company ...
com-unik.info
11/17/2022 1 in 4 US adults suffer from chronic knee pain: Survey
Nearly 1 in 4 adults in the U.S. suffer from chronic knee pain, according to a new survey from Pacira Biosciences. Of 500 survey respondents who have been treated for chronic knee pain or osteoarthritis, 97 percent said their daily lives are still negatively affected by pain. Patients reported effects ...
Beckers Spine Review
11/17/2022 New Research Reveals Common Treatments for Knee Pain are Falling Short, Placing Physical, Social, and Mental Burden on Patients | Markets Insider
... revealing that more Americans are living for years without adequate pain relief. Experience the full interactive Multichannel News Release here: https://www.multivu.com/players/English/9104351-pacira-iovera-knee-pain-survey/ The national survey, Standing Up to Knee Pain: The Physical, Social, and Mental Impact of Knee OA, polled 500 U.S ...
Business Insider
11/17/2022 Pacira BioSciences (NASDAQ:PCRX) Shares Down 3.3% - Transcript Daily
Pacira BioSciences, Inc. ( NASDAQ:PCRX ‚Ai Get Rating )'s share price dropped 3.3% on Tuesday . The stock traded as low as $49.30 and last traded at $49.32. Approximately 10,769 shares changed hands during mid-day trading, a decline of 97% from the average daily volume of 395,599 shares. The stock ...
transcriptdaily.com
11/17/2022 Pacira BioSciences (NASDAQ:PCRX) Shares Down 3.3% - Stock Observer
Pacira BioSciences, Inc. ( NASDAQ:PCRX ‚Ai Get Rating )'s stock price dropped 3.3% during mid-day trading on Tuesday . The company traded as low as $49.30 and last traded at $49.32. Approximately 10,769 shares traded hands during mid-day trading, a decline of 97% from the average daily volume of ...
thestockobserver.com